Findlay, John M. http://orcid.org/0000-0001-5786-4086
Antonowicz, Stefan
Segaran, Ashvina
el Kafsi, Jihene
Zhang, Alexa
Bradley, Kevin M.
Gillies, Richard S.
Maynard, Nicholas D.
Middleton, Mark R.
Funding for this research was provided by:
University of Oxford
Article History
Received: 3 September 2018
Revised: 26 October 2018
Accepted: 22 November 2018
First Online: 14 January 2019
Compliance with ethical standards
:
: The scientific guarantor of this publication is John Findlay.
: The authors of this manuscript declare relationships with the following companies:MRM has the following roles to disclose:Advisory/consulting role (payment to the individual) Amgen, BMS, GSK, Merck, Millennium, Physiomics, and Roche. Research funding (payment to the institution) from Amgen, AZ, BMS, Clovis, Eisai, GSK, Immunocore, Johnson & Johnson, Merck, Millennium, Novartis, Pfizer, Roche, and Vertex. JMF has the following roles to disclose: Unremunerated advisory role to Physiomics
: One of the authors (JMF) has significant statistical expertise.
: Written informed consent was waived by the Institutional Review Board.
: Institutional Review Board approval was obtained.
: • retrospective• diagnostic or prognostic study• performed at one institution